FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073433 [Registered on: 05/09/2024] Trial Registered Prospectively
Last Modified On: 04/09/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device
Process of Care Changes 
Study Design  Single Arm Study 
Public Title of Study   Glaucoma Medication Adherence Study 
Scientific Title of Study   Assessment of the role of regular text messages, audio-visual reminders using adherence monitors, and one on one counselling on the adherence to topical medications in patients with glaucoma - A non-randomized study 
Trial Acronym  AGMAS 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Swati Upadhyaya 
Designation  Consultant 
Affiliation  Aravind Eye Hospital, Pondicherry 
Address  Room No. 21, First floor, Glaucoma Clinic, Aravind Eye Hospital Thavalakuppam Cuddalore Main road

Pondicherry
PONDICHERRY
605007
India 
Phone  8489810704  
Fax  -  
Email  swati.dr@aravind.org  
 
Details of Contact Person
Scientific Query
 
Name  Swati Upadhyaya 
Designation  Consultant 
Affiliation  Aravind Eye Hospital, Pondicherry 
Address  Room No. 21, First floor, Glaucoma Clinic, Aravind Eye Hospital Thavalakuppam Cuddalore Main road


PONDICHERRY
605007
India 
Phone  8489810704  
Fax  -  
Email  swati.dr@aravind.org  
 
Details of Contact Person
Public Query
 
Name  Swati Upadhyaya 
Designation  Consultant 
Affiliation  Aravind Eye Hospital, Pondicherry 
Address  Room No. 21, First floor, Glaucoma Clinic, Aravind Eye Hospital Thavalakuppam Cuddalore Main road


PONDICHERRY
605007
India 
Phone  8489810704  
Fax  -  
Email  swati.dr@aravind.org  
 
Source of Monetary or Material Support  
W K Kellogg Eye Centre, Ann Arbor, Michigan 
 
Primary Sponsor  
Name  W K Kellogg Eye Centre, Michigan 
Address  1000 Wall St, Ann Arbor, Michigan, 48109 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Swati Upadhyaya  Aravind Eye Hospital, Pondicherry  Thavalakuppam, Cuddalore Main Road
Pondicherry
PONDICHERRY 
8489810704

swati.dr@aravind.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Aravind Eye Hospital, Pondicherry  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H401||Open-angle glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  as 
 
ExclusionCriteria 
Details  1. Newly diagnosed patients with glaucoma
2. Glaucoma patients with uncontrolled IOP
3. Glaucoma patients who are not on stable medications
4. Ocular hypertension (OHT)
5. Normal tension glaucoma
6. Secondary glaucomas like immediate post-surgical, steroid induced which might not need long term anti-glaucoma medications
7. History of intraocular surgery within the previous 3 months
8. People with cognitive decline – BCVA in the better eye less than 6/60, poor hearing requiring hearing aids
9. Illiterate patients
10. Pregnant / nursing mothers
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. To assess the change in mean adherence from baseline following regular text messages, audio-visual reminders using adherence monitors and counselling
2. To assess the proportion of participants with improved adherence from baseline following regular text messages, audio-visual reminders using adherence monitors and counselling
 
6 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. To assess the barriers for adherence based on a survey questionnaire
2. To assess the participant feedback regarding the three methods of intervention - regular text messages, audio-visual reminders using adherence monitors and counselling using a feedback form
3. To assess whether there is an incremental response in adherence when multiple methods are used sequentially
4. To assess the proportion of participants with ≥80% adherence
 
6 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   23/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="11"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

High rates of poor adherence to effective medications is a key modifiable barrier to better outcomes for people with glaucoma. Various methods to modify the adherence that have been described in literature including patient education interventions, counselling, personalized glaucoma coaching programs, giving written instructions, reminder systems, rescheduling of eye drop therapy with simplification of dosing, eye drop instillation training, creation of a glaucoma club among others.

Through this study, we aim to assess the benefit of regular text messages, audio-visual reminders using adherence monitors and counselling on the adherence to topical medications in patients with glaucoma in a south Indian population.

We hypothesize that the adherence to topical anti-glaucoma medications would improve by providing reminders or intensive counselling sessions to the participants. A reminder text message service if found beneficial, may also be provided by subscription to the patients in the future. 

 
Close